Evidence map›Paper›PMID 29756027›Full record

ArticleeNeuro

Translatome Regulation in Neuronal Injury and Axon Regrowth.

Meir Rozenbaum, Marek Rajman, Ida Rishal, Indrek Koppel, Sandip Koley, Katalin F Medzihradszky, Juan A Oses-Prieto, Riki Kawaguchi, Paul S Amieux, Alma L Burlingame and 2 more

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Analysis of translatomic changes in theFrontiers in neurology · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Integrin-Driven Axon Regeneration in the Spinal Cord Activates a Distinctive CNS Regeneration Program.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Meir RozenbaumDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Marek RajmanDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-9060-2432
Ida RishalDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Indrek KoppelDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Sandip KoleyDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Katalin F MedzihradszkyDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158-2517.
Juan A Oses-PrietoDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158-2517.
Riki KawaguchiDepartments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90095.
Paul S AmieuxDepartment of Pharmacology, University of Washington, Seattle, WA 98195.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158-2517.
Giovanni CoppolaDepartments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90095.ORCID 0000-0003-2105-1061
Mike FainzilberDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-8173-8557
Weizmann Institute of Science · ILUniversity of California, San Francisco · USUniversity of California, Los Angeles · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcriptional events leading to outgrowth of neuronal axons have been intensively studied, but the role of translational regulation in this process is not well understood. Here, we use translatome analyses by ribosome pull-down and protein synthesis characterization by metabolic isotopic labeling to study nerve injury and axon outgrowth proteomes in rodent dorsal root ganglia (DRGs) and sensory neurons. We identify over 1600 gene products that are primarily translationally regulated in DRG neurons after nerve injury, many of which contain a 5'UTR cytosine-enriched regulator of translation (CERT) motif, implicating the translation initiation factor Eif4e in the injury response. We further identified approximately 200 proteins that undergo robust de novo synthesis in the initial stages of axon growth. ApoE is one of the highly synthesized proteins in neurons, and its receptor binding inhibition or knockout affects axon outgrowth. These findings provide a resource for future analyses of the role of translational regulation in neuronal injury responses and axon extension.

Indexed as

AnimalsAxonsCell Culture TechniquesGanglia, SpinalGene Expression RegulationMaleMiceMice, Inbred C57BLNerve RegenerationNeuronal OutgrowthPeripheral Nerve InjuriesProtein BiosynthesisProteomicsRatsRats, WistarSensory Receptor Cellsaxon growthaxon injurynerve regenerationtranslational regulation

Identifiers

PMID29756027
PMCPMC5944006
OpenAlexW2801451800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.